Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed

Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed GlobeNewswire September 04, 2025 Press Release Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed Company expects to fully repay existing financial debts in 2026 NCX 470 NDA submissions in U.S. (H1 2026) and subsequently in […]

IRLAB Is Granted a Patent Strengthening the Market Exclusivity of The Drug Candidate Mesdopetam in China

GOTHENBURG, SE / ACCESS Newswire / September 4, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson’s disease, today announced that the company has been granted an additional ‘composition of matter patent’ in China. The patent protects the salt of mesdopetam intended for use in the forthcoming

Kuros Biosciences announces changes in the Board of Directors

(SWX:KURN), Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences announces changes in the Board of Directors Schlieren (Zurich), Switzerland, September 4, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, announces that Albert Arp has decided to resign from the Board of Directors

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

(Paris:SAN), Sanofi's amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every four weeks or every 12 weeks, demonstrated statistically significant and clinically meaningful efficacy in skin clearance and disease severity compared to placebo at Week 24, with efficacy progressively

Kuros Biosciences announces changes in the Board of Directors

Kuros Biosciences announces changes in the Board of Directors GlobeNewswire September 04, 2025 Ad-hoc announcement pursuant to Article 53 of the SIX listing rules Kuros Biosciences announces changes in the Board of Directors Schlieren (Zurich), Switzerland, September 4, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader in next generation bone healing technologies, announces

Press Release: Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis

Press Release: Sanofi's amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis GlobeNewswire September 04, 2025 Sanofi's amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Amlitelimab, dosed every

Samsonite Launches Paralux™ Collection Worldwide: A New Standard in Sustainable Design and Intuitive Organization

Design Converges with Sustainability: The Paralux Collection Combines More Sustainable Materials with Innovative Functionality for Life on the Move Samsonite, the iconic and trusted leader in travel gear headquartered in Luxembourg City, LU, and Massachusetts, USA, unveils the Paralux Collection, hardside luggage and bags thoughtfully engineered for travelers who value design, efficiency, and sustainability. Merging

Honda to Begin Sales of All-new Prelude

Honda Motor Co., Ltd. (Honda) will begin sales in Japan of the all-new Prelude tomorrow, on September 5, 2025. Inspired by the image of gliders soaring freely and boundlessly through the open sky, Honda developed the all-new Prelude under the grand concept of "Unlimited Glide," striving for a vehicle that evokes the uplifting sensation of

Scroll to Top